Letter to the Editor Regarding Comparative Efficacy of JAK Inhibitors for Moderate-to-Severe Rheumatoid Arthritis: A Network Meta-Analysis

Detalles Bibliográficos
Autores principales: Fakhouri, Walid, Sapin, Christophe, Holzkaemper, Thorsten, de la Torre, Inmaculada
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2021
Materias:
Letter
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8107070/
https://www.ncbi.nlm.nih.gov/pubmed/33742363
http://dx.doi.org/10.1007/s12325-021-01641-w
_version_ 1783689888019775488
author Fakhouri, Walid
Sapin, Christophe
Holzkaemper, Thorsten
de la Torre, Inmaculada
author_facet Fakhouri, Walid
Sapin, Christophe
Holzkaemper, Thorsten
de la Torre, Inmaculada
author_sort Fakhouri, Walid
collection PubMed
description
format Online
Article
Text
id pubmed-8107070
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Springer Healthcare
record_format MEDLINE/PubMed
spelling pubmed-81070702021-05-24 Letter to the Editor Regarding Comparative Efficacy of JAK Inhibitors for Moderate-to-Severe Rheumatoid Arthritis: A Network Meta-Analysis Fakhouri, Walid Sapin, Christophe Holzkaemper, Thorsten de la Torre, Inmaculada Adv Ther Letter Springer Healthcare 2021-03-20 2021 /pmc/articles/PMC8107070/ /pubmed/33742363 http://dx.doi.org/10.1007/s12325-021-01641-w Text en © The Author(s) 2021 https://creativecommons.org/licenses/by-nc/4.0/Open AccessThis article is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License, which permits any non-commercial use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) .
spellingShingle Letter
Fakhouri, Walid
Sapin, Christophe
Holzkaemper, Thorsten
de la Torre, Inmaculada
Letter to the Editor Regarding Comparative Efficacy of JAK Inhibitors for Moderate-to-Severe Rheumatoid Arthritis: A Network Meta-Analysis
title Letter to the Editor Regarding Comparative Efficacy of JAK Inhibitors for Moderate-to-Severe Rheumatoid Arthritis: A Network Meta-Analysis
title_full Letter to the Editor Regarding Comparative Efficacy of JAK Inhibitors for Moderate-to-Severe Rheumatoid Arthritis: A Network Meta-Analysis
title_fullStr Letter to the Editor Regarding Comparative Efficacy of JAK Inhibitors for Moderate-to-Severe Rheumatoid Arthritis: A Network Meta-Analysis
title_full_unstemmed Letter to the Editor Regarding Comparative Efficacy of JAK Inhibitors for Moderate-to-Severe Rheumatoid Arthritis: A Network Meta-Analysis
title_short Letter to the Editor Regarding Comparative Efficacy of JAK Inhibitors for Moderate-to-Severe Rheumatoid Arthritis: A Network Meta-Analysis
title_sort letter to the editor regarding comparative efficacy of jak inhibitors for moderate-to-severe rheumatoid arthritis: a network meta-analysis
topic Letter
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8107070/
https://www.ncbi.nlm.nih.gov/pubmed/33742363
http://dx.doi.org/10.1007/s12325-021-01641-w
work_keys_str_mv AT fakhouriwalid lettertotheeditorregardingcomparativeefficacyofjakinhibitorsformoderatetosevererheumatoidarthritisanetworkmetaanalysis
AT sapinchristophe lettertotheeditorregardingcomparativeefficacyofjakinhibitorsformoderatetosevererheumatoidarthritisanetworkmetaanalysis
AT holzkaemperthorsten lettertotheeditorregardingcomparativeefficacyofjakinhibitorsformoderatetosevererheumatoidarthritisanetworkmetaanalysis
AT delatorreinmaculada lettertotheeditorregardingcomparativeefficacyofjakinhibitorsformoderatetosevererheumatoidarthritisanetworkmetaanalysis

Ejemplares similares